WATCH NOW
Biogen Webinar | May 2025
On Thursday, May 22, 2025, Biogen joined FARA for an informational webinar about the upcoming BRAVE study: a global Phase 3 pediatric study for omaveloxolone.
On Thursday, May 22, 2025, Biogen joined FARA for an informational webinar about the upcoming BRAVE study: a global Phase 3 pediatric study for omaveloxolone.